Reactive Astrogliosis: Role in Alzheimer's Disease.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  CNS and Neurological Disorders - Drug Targets

• Publication date

  2015-08-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1871527314666150713104738PMID 26166438
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Learning and memory: Putting limits on learning

  2014cited by this paper
• Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk

  2014cited by this paper
• Antioxidative effects of Panax notoginseng saponins in brain cells.

  2014cited by this paper
• Role of Scavenger Receptors in Glia-Mediated Neuroinflammatory Response Associated with Alzheimer's Disease

  2013cited by this paper
• Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial.

  2013cited by this paper
• Astrocyte Regulation of CNS Inflammation and Remyelination

  2013cited by this paper
• Quantitative structure activity relationship analysis of aminoimidazoles as BACE-I inhibitors

  2013cited by this paper
• Link between Cancer and Alzheimer Disease via Oxidative Stress Induced by Nitric Oxide-Dependent Mitochondrial DNA Overproliferation and Deletion

  2013cited by this paper
• Astrocytes and glutamate homoeostasis in Alzheimer's disease: a decrease in glutamine synthetase, but not in glutamate transporter-1, in the prefrontal cortex

  2013cited by this paper
• Dietary Antioxidants and Dementia in a Population-Based Case-Control Study among Older People in South Germany

  2012cited by this paper
• Glial connexin expression and function in the context of Alzheimer's disease.

  2012cited by this paper
• Mitochondria-targeted antioxidants as therapies.

  2011cited by this paper
• Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States

  2011cited by this paper
• Amyloid‐β‐induced reactive oxygen species production and priming are differentially regulated by ion channels in microglia

  2011cited by this paper
• Microglia and inflammation in Alzheimer's disease.

  2010cited by this paper
• Abnormal Mitochondrial Dynamics—A Novel Therapeutic Target for Alzheimer's Disease?

  2010cited by this paper
• Activated astroglia during chronic inflammation in Alzheimer's disease--do they neglect their neurosupportive roles?

  2010cited by this paper
• Astrocytes in Alzheimer's Disease: Emerging Roles in Calcium Dysregulation and Synaptic Plasticity

  2010cited by this paper
• Aminoimidazoles as potent and selective human beta-secretase (BACE1) inhibitors.

  2009cited by this paper
• Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease

  2009cited by this paper
• Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity

  2009cited by this paper
• ApoE promotes the proteolytic degradation of Abeta.

  2008cited by this paper
• Oxidative stress hypothesis in Alzheimer's disease: a reappraisal.

  2008cited by this paper
• Astroglial Metabolic Networks Sustain Hippocampal Synaptic Transmission

  2008cited by this paper
• Apolipoprotein E

  2007cited by this paper
• Calcium-regulated signaling pathways

  2007cited by this paper
• Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities

  2007cited by this paper
• Neuroprotective effects of curcumin.

  2007cited by this paper
• Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.

  2006cited by this paper
• Genetic basis of Alzheimer's dementia: role of mtDNA mutations

  2006cited by this paper
• Brain Cholesterol Synthesis in Mice Is Affected by High Dose of Simvastatin but Not of Pravastatin

  2006cited by this paper
• Apolipoprotein E and Alzheimer disease

  2006cited by this paper
• Proinflammatory cytokines released from microglia inhibit gap junctions in astrocytes: potentiation by β‐amyloid

  2006cited by this paper
• Apolipoprotein E decreases tau kinases and phospho-tau levels in primary neurons

  2006cited by this paper
• Global prevalence of dementia: a Delphi consensus study

  2005cited by this paper
• Differential effects of oligomeric and fibrillar amyloid-beta 1-42 on astrocyte-mediated inflammation.

  2005cited by this paper
• Satellite glial cells in sensory ganglia: from form to function.

  2005cited by this paper
• The role of inflammation in Alzheimer's disease.

  2005cited by this paper
• Statins: drugs for Alzheimer’s disease?

  2005cited by this paper
• Pro‐regenerative properties of cytokine‐activated astrocytes

  2004cited by this paper
• Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease.

  2004cited by this paper
• ABCA1 Is Required for Normal Central Nervous System ApoE Levels and for Lipidation of Astrocyte-secreted apoE*

  2004cited by this paper
• Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease.

  2004cited by this paper
• Neuronal and glial calcium signaling in Alzheimer's disease.

  2003cited by this paper
• Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells

  2003cited by this paper
• Human beta-secretase (BACE) and BACE inhibitors.

  2003cited by this paper
• Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts

  2003cited by this paper
• Glutamate uptake.

  2001cited by this paper
• Dementia and Race: Are There Differences Between African Americans and Caucasians?

  2001cited by this paper
• Expression of prostaglandin E synthase mRNA is induced in beta-amyloid treated rat astrocytes.

  2000cited by this paper
• Genetic diseases and gene knockouts reveal diverse connexin functions.

  1999cited by this paper
• Alzheimer's disease

  1998cited by this paper
• Phosphorylation of microtubule‐associated protein tau by stress‐activated protein kinases

  1997cited by this paper
• Glutamate Transporter Alterations in Alzheimer Disease Are Possibly Associated with Abnormal APP Expression

  1997cited by this paper
• Elevated connexin43 immunoreactivity at sites of amyloid plaques in Alzheimer's disease.

  1996cited by this paper
• Connections with connexins: the molecular basis of direct intercellular signaling.

  1996cited by this paper
• Microglia, the first line of defence in brain pathologies.

  1995cited by this paper
• Microglia: intrinsic immuneffector cell of the brain.

  1995cited by this paper
• Glutamate-induced intracellular calcium changes and neurotoxicity in cortical neurons in vitro: effect of chemical ischemia.

  1994cited by this paper
• The role of complement in inflammation and phagocytosis.

  1991cited by this paper
• Parvalbumin-immunoreactive structures in the hippocampus of the human adult

  1991cited by this paper
• Molecular organization and function of the complement system.

  1988cited by this paper

• Mitochondrial Fragmentation as a Key Driver of Neurodegenerative Disease.

  2025cites this paper
• Neuroinflammation and Alzheimer's disease: Unravelling the molecular mechanisms

  2025cites this paper
• Glial fibrillary acidic protein in Alzheimer’s disease: a narrative review

  2024cites this paper
• Circulating small extracellular vesicles in Alzheimer’s disease: a case–control study of neuro-inflammation and synaptic dysfunction

  2024cites this paper
• The Nerve Growth Factor Receptor (NGFR/p75NTR): A Major Player in Alzheimer’s Disease

  2023cites this paper
• Alzheimer ’ s disease as a viral disease: Revisiting the infectious hypothesis ☆

  2023cites this paper
• Sex-Dependent Altered Expression of Cannabinoid Signaling in Hippocampal Astrocytes of the Triple Transgenic Mouse Model of Alzheimer’s Disease: Implications for Controlling Astroglial Activity

  2023cites this paper
• Xeno-Free Biomimetic ECM Model for Investigation of Matrix Composition and Stiffness on Astrocyte Cell Response

  2023cites this paper
• Serum Levels of Glial Fibrillary Acidic Protein Association with Cognitive Impairment and Type 2 Diabetes.

  2022cites this paper
• Fragmentation of rest periods, astrocyte activation, and cognitive decline in older adults with and without Alzheimer's disease

  2022cites this paper
• Cutaneous burn injury induces neuroinflammation and reactive astrocyte activation in the hippocampus of agedz mice.

  2022cites this paper
• Age-Related Deficits in Working Memory in 5xFAD Mice in the Hebb-Williams Maze.

  2022cites this paper
• Astrocytic 4R tau expression drives astrocyte reactivity and dysfunction

  2021cites this paper
• Disrupting Neurons and Glial Cells Oneness in the Brain—The Possible Causal Role of Herpes Simplex Virus Type 1 (HSV-1) in Alzheimer’s Disease

  2021cites this paper
• Zinc induces reactive astrogliosis through ERK‐dependent activation of Stat3 and promotes synaptic degeneration

  2021cites this paper
• Combinatorial analyses reveal cellular composition changes have different impacts on transcriptomic changes of cell type specific genes in Alzheimer’s Disease

  2020cites this paper
• Glycogen Synthase Kinase 3 (GSK3): Its Role and Inhibitors.

  2020cites this paper
• Astrocytic palmitoylethanolamide pre-exposure exerts neuroprotective effects in astrocyte-neuron co-cultures from a triple transgenic mouse model of Alzheimer's disease.

  2020cites this paper
• Effects of the Novel IDO Inhibitor DWG-1036 on the Behavior of Male and Female 3xTg-AD Mice

  2019cites this paper
• Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development

  2019cites this paper
• Age and sex differences in motivation and spatial working memory in 3xTg-AD mice in the Hebb-Williams maze.

  2019cites this paper
• Effects and mechanism of amyloid β1-42 on mitochondria in astrocytes

  2018cites this paper
• Commissural white matter disconnectivity in normal ageing and Alzheimer’s disease

  2018cites this paper
• Curcumin Ameliorates Neuroinflammation, Neurodegeneration, and Memory Deficits in p25 Transgenic Mouse Model that Bears Hallmarks of Alzheimer’s Disease

  2017cites this paper
• Astrocytes Surviving Severe Stress Can Still Protect Neighboring Neurons from Proteotoxic Injury

  2016cites this paper
• Rational design, synthesis and in vitro evaluation of allylidene hydrazinecarboximidamide derivatives as BACE-1 inhibitors.

  2016cites this paper
• Neuroteratology and Animal Modeling of Brain Disorders.

  2016cites this paper
• Design, synthesis and in vitro evaluation studies of sulfonyl-amino-acetamides as small molecule BACE-1 inhibitors.

  2016cites this paper
• Glial cells as drug targets: What does it take?

  2016cites this paper
• Neurotoxin Modeling of Brain Disorders—Life-long Outcomes in Behavioral Teratology

  2016cites this paper
• Integrated 18F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging (18F-FDG PET/MRI), a multimodality approach for comprehensive evaluation of dementia patients: A pictorial essay

  2015cites this paper
• Reduction in Aβ‐induced cell death in the hippocampus of 17β‐estradiol‐treated female rats is associated with an increase in IGF‐I signaling and somatostatinergic tone

  2015cites this paper